p14 Arf ͉ apoptosis ͉ cancer ͉ extracellular matrix
p53 mediates apoptosis of cells after DNA damage including tumor cells after radiation or chemotherapy. Survival of isolated cancer cells after therapy leads to recurrence of therapy-resistant tumors. We now show that for some melanoma, sarcoma, or fibroblastic cell types that survive without integrin-mediated adhesion, apoptosis in response to DNA damage requires cell adhesion. This effect correlates with rapid changes in levels of p14͞p19 Arf and its downstream component, p53. Killing of nonadherent cells is increased by treatment with antiintegrin antibodies or by increasing levels of p53 or Arf. Consistent with low p53 levels, suspended cells show chromosomal instability after irradiation. Thus, loss of normal adhesion in susceptible tumor cells during genotoxic stress may play a role in therapy resistance and promote survival of cells with aberrant DNA.
p14 Arf ͉ apoptosis ͉ cancer ͉ extracellular matrix A poptosis is a key component in the development and maintenance of tissues within mammalian organisms, providing a mechanism to eliminate damaged or unnecessary cells (1) (2) (3) . Conventional cancer therapies take advantage of this mechanism by employing ionizing radiation or chemicals to damage DNA and induce selective apoptosis of rapidly growing cells. However, killing of tumor cells commonly is incomplete, allowing tumor recurrence and progression toward more aggressive phenotypes. Understanding the molecular mechanisms by which DNA damage induces cells to undergo apoptosis therefore is an important goal.
Apoptosis in response to DNA damage involves a complex pathway in which p53 and p53 family members play critical regulatory roles. P53 is a tumor suppressor protein that serves as a molecular switch between different cell fates after DNA damage and other stresses, leading to either apoptosis or cell-cycle arrest (1) (2) (3) . The importance of p53 is underscored by the fact that most human cancers are found to have lost this pathway and that its loss is a critical event in the transition to therapy resistance (1) . p53 normally is maintained at low levels largely because of Mdm2-mediated degradation (4, 5) . As few as one double-strand break (6) can trigger events that decrease the interaction of p53 with Mdm2 to increase p53 levels. Phosphorylation of p53 at serines 15 and 20 by ATM and CHK2, respectively, block binding to Mdm2 to stabilize p53 (7) . Additionally, increased p19Arf inhibits the action of Mdm2 by sequestering it within nucleoli to increase p53 levels (4, 8) . Increased p53 results in transactivation of a number of targets including genes that control cell growth, apoptosis, and DNA repair (9) (10) (11) . After DNA damage, p53 mediates a delay in the G 1 phase of the cell cycle to permit DNA repair to occur (12, 13) . Alternatively, if DNA damage is severe, p53 promotes apoptosis (1) .
Integrins are receptors that mediate attachment and spreading on extracellular matrix (ECM) proteins and transduce signals that regulate cell growth, survival, and gene expression (14) . Integrins regulate diverse pathways including activation of protein tyrosine and serine͞threonine kinases, lipid kinases, and small GTPases (15, 16) . With regard to survival, some cell-type specificity has been noted. In epithelial and endothelial cells, integrin ligation regulates cell survival such that detachment from the ECM rapidly induces apoptosis (17, 18) . In some of these cases, cell death results from increased levels of p53 or Bax caused by detachment or inhibition of integrins or by overexpression of unligated integrins (19) (20) (21) . Correspondingly, binding of some carcinomas to the ECM protects against apoptosis initiated by DNA damage (22) . However, in transformed epithelial cells and fibroblastic cell types, ligation of integrins is not required for survival, and detachment from the ECM is not sufficient to trigger apoptosis (23) .
We now show that in some melanoma, sarcoma, and fibroblastic cell types that survive in suspension, detachment from the ECM unexpectedly decreases cell death after DNA damage. The mechanism involves integrin-dependent changes in p14͞p19 Arf and p53 levels. Consistent with decreased p53, loss of cell adhesion also induces genetic instability. These results suggest a mechanism by which tumor cells can escape radiation or chemotherapy, acquire additional mutations, and progress toward more aggressive forms. ϩ͞ϩ cells also were maintained in DMEM supplemented with 10% FCS. Cells detached from the substratum were resuspended in either standard medium for short times (Ͻ1 h) or medium containing 0.8% carboxymethylcellulose for longer times to inhibit cell aggregation. To induce apoptosis, cells were treated with 1-20 M of the DNA-damaging reagent 5-arabinofuranosylcytosine (ara C) for 24-48 h. Alternatively, cells were irradiated by using a Gammacell 1,000 cesium source. Terminal deoxynucleotidyltransferase-mediated UTP end labeling (TUNEL) assays were performed by using the labeling kit from Roche Molecular Biochemicals according to manufacturer instructions. Cells were scored by using fluorescence microscopy.
Materials and Methods
Antibody Inhibition. HT1080 fibrosarcoma cells were either kept adherent or detached and resuspended in methylcellulose. At 2 h, ara C was added to some samples. At 2.5 h, 0.5 g͞ml of the purified antiintegrin antibodies P5D2 (Developmental Studies Hybridoma Bank, University of IA, Iowa City), LM534 or LM609 (both kindly provided by D. Cheresh, Scripps Research Institute), or the control antibody 2D3 against CD47 integrinassociated protein (IAP), a gift of E. Brown (Washington University School of Medicine, St. Louis) were added to samples. The addition of antibodies was repeated each hour for a total of 4 doses. After 48 h, lysates were prepared, and caspase-3 activity was measured.
Apoptosis Assays. For analysis of caspase-3 activation, cell lysates were prepared in 50 mM Hepes, pH 7.4 containing 0.1% CHAPS {3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate}, 0.1 mM EDTA, and 1 mM DTT. Samples were assayed in lysis buffer supplemented with 100 mM NaCl and 10% glycerol using the colorimetric substrate Asp-Glu-Val-Asp (DEVD)-p-nitroanilide with or without the caspase-3 inhibitor Ac-DEVD-CHO (Alexis Biochemicals, San Diego). Background activity (in the presence of inhibitor) was subtracted to obtain specific caspase-3 activity.
Western Blotting. Cells were lysed in immunoprecipitation assay buffer containing protease inhibitors as described (24) . Equal amounts of protein were separated by SDS͞PAGE, transferred to nitrocellulose, and developed with antibodies as indicated. Blots were visualized with ECL (Amersham Pharmacia). 
MEFs on a p53
Ϫ͞Ϫ background were transfected with green fluorescent protein (GFP)-p53 using Effectene according to manufacturer instructions (Qiagen, Chatsworth, CA). Cells were put into suspension at 24 h posttransfection and harvested at the times indicated in the figures. MEFs in 10-cm dishes were transfected with GFP-p53 or GFP-Arf (0.5 g) plus GFP-GTPase-activating protein (GAP, 1 g) as a marker for transfection. Cells were put into suspension at 24 h and analyzed for apoptosis at 48 h. The pEGFP-N1 vector expressing GFP-p53 was a generous gift from G. Wahl (Salk Institute, La Jolla, CA). A vector expressing the plasma membrane-targeting protein, GFP-GAP, was kindly provided by A. Horwitz (University of Virginia, Charlottesville, VA). A vector expressing GFP-Arf was a gift of C. Scherr (St. Jude Children's Research Hospital, Memphis, TN).
Karyotype Analysis. MEFs subjected to 7.5 Gy of gamma irradiation were either replated or kept in suspension for 48 h and allowed to recover. Surviving cells were cultured and expanded for 2-4 weeks. After incorporation of BrdUrd (Sigma), cells were treated with colchicine (KaryoMax, GIBCO͞BRL) to arrest cells in mitosis. Metaphases from adherent or suspended cell samples were prepared as described (25) . Fixed samples were labeled with anti-BrdUrd antibodies (Sigma) and propidium iodide. Individual metaphases were photographed. Photographic files were shuffled and scored blind for the presence of structural chromosomal aberrations as described by Savage (26) .
Results
Cell Adhesion Potentiates Apoptosis in Response to DNA Damage. We wished to investigate whether integrin ligation can influence the apoptotic response to DNA damage for tumor cells that survive in suspension. We began by analyzing the response of HT1080 fibrosarcoma cells to DNA damage. We used the drug ara C to induce single-and double-strand breaks and assayed apoptosis in adherent and detached cells. Whereas adherent HT1080 cells showed substantial levels of apoptosis in response to a low dose Cell lysates were prepared, and caspase-3 activity was measured. Values are means Ϯ SE; n ϭ 3. (F) MEFs were either kept adherent or detached and resuspended in methylcellulose. At 2 h, ara C was added to some samples. After 4 h in suspension, lysates were prepared, and samples containing equal protein were immunoblotted by using a polyclonal antibody against phospho-serine 345 Chk1 (Cell Signaling Technology, Beverly, MA).
of ara C as assayed by the TUNEL reaction, cells maintained in suspension for 2 h before ara C exposure showed minimal cell death (Fig. 1A) . Additionally, by 3-4 days after treatment nearly 100% of adherent cells were morphologically apoptotic, whereas suspended cells could be replated and remained viable for at least 5 days (data not shown). These data also show that cell detachment confers resistance to DNA damage, not merely a delay in onset of apoptosis. Activity of caspase-3, the executioner caspase, was measured as an independent assay for apoptosis (Fig. 1B) . ara C triggered an increase in caspase-3 activity in adherent but not suspended cells correlating with the increased percentage of TUNEL-labeled cells.
Cell-Type Specificity. To investigate the generality of these results we examined several other cell types. Although different cell types showed some variation in dose-response curves to ara C (data not shown), M21L human melanoma cells showed a similar adhesion dependence for ara C-induced apoptosis ( Fig. 2A) , as did human rhabdomyosarcoma cells (data not shown). By contrast, the A375 human melanoma line activated caspase-3 in both adherent and suspended cells after ara C treatment (Fig. 2B) . Other cell types examined were not amenable to analysis, because they either were resistant to ara C treatment or the untreated cells died in suspension without ara C. Several normal or carcinoma cell lines including MCF10A epithelial cells and MCF7 breast, A431 bladder, and Du145 prostate carcinomas fell into the latter category. Finally, we tested primary MEFs, because their normal diploid chromosomal structure and the availability of cells from knockout mice could facilitate further studies. MEFs also showed diminished sensitivity to araC when nonadherent (Fig. 2C) . These data suggest that the ability of cell detachment to decrease sensitivity to DNA damage may be relatively common among cells that can survive without adhesion but that it clearly shows some cell-type specificity.
We also tested gamma irradiation as a source of DNA damage. In these experiments, all cells by technical necessity were treated in suspension, which further equalized the conditions of treatment. Adherent cell samples were replated immediately after treatment. Adherent but not suspended M21L cells (Fig. 2D) were sensitive to irradiation, as were MEFs (Fig. 2E ) and HT1080 cells (data not shown).
Controls.
Despite the difference in cell death, adherent and suspended cells showed no difference in activation of Chk1, indicating that neither DNA damage itself nor the early response to DNA damage were affected (Fig. 2F) . Furthermore, when cells were treated with ara C immediately after detachment from the substratum, they still underwent apoptosis in response to DNA damage (data not shown). Conversely, suspended cells replated immediately after treatment with ara C showed high levels of apoptosis (data not shown but see Fig. 2 D and E for a similar experiment using gamma radiation). These results exclude a number of potential artifacts (for example, decreased uptake of ara C in suspended cells) and suggest that there are temporal effects on adhesion-dependent pathways after changes in adhesion status. The results also show that these effects are reversible.
Role of Integrins.
To investigate the involvement of integrins, various antibodies were tested for their ability to restore the apoptosis response in suspended HT1080 fibrosarcoma cells (Fig. 3 ). An antibody against the Ig family protein CD47 (IAP, ref. 27 ) was used as a control. Both anti-IAP and antiintegrin IgGs appeared to cause a slight increase in caspase-3 activation in suspended cells even in the absence of ara C. Treatment of suspended cells with the anti-␤1 integrin antibodies LM534 and P5D2 or the anti-␣v␤3 antibody LM609 restored sensitivity to ara C, whereas the control IgG had no effect. These data are consistent with studies showing that ligation or crosslinking of integrins with soluble IgGs activate integrin-signaling pathways (28, 29) and demonstrate that integrins mediate these effects.
Arf and p53 Levels Decline Rapidly When Cells Are Kept in Suspension.
p53 and its upstream regulators p14͞19 Arf and Mdm2 comprise a major regulatory pathway for the DNA-damage response in mammalian cells. We therefore investigated the effects of cell adhesion on these components. After detachment of MEFs, Arf protein levels declined dramatically, showing changes within 15 min (Fig. 4A) . Levels of Arf continued to decline such that by 90 min Arf was Ϸ10% of levels in adherent cells and remained low for at least 3 h. An antiintegrin antibody partially restored Arf levels in suspended cells (Fig. 3B) . The recovery of Arf was not complete, most likely reflecting the limitations of soluble integrin antibodies that tend to induce only transient signals (30) , but was likely to be sufficiently above threshold levels. Notably, Arf in suspended A375 cells, which remain sensitive to DNA damage, did not decline and even showed a modest increase (Fig. 4B) . Sensitivity to DNA damage and the integrin regulation of Arf therefore are correlated.
Analysis of p53 showed that after detachment, p53 protein levels declined with a slower time course (Fig. 4A) . Levels of p53 in suspended MEFs remained low for up to 18 h (data not shown). Suspended cells treated with ara C initially increased p53, but levels still declined after 4 h in suspension. This rate correlates with the time required for cells to become resistant to DNA damage after detachment as described above. In HT1080 fibrosarcoma and RD rhabdomyosarcoma cells, p53 was also much lower after detachment ( Fig. 4C ; HT1080 cells have wild-type p53, and RD cells have p53 mutated in the DNA-binding region; refs. 31 and 32). By contrast, no changes in the level of Mdm2 were observed (Fig. 4A) . As expected, p53 Ϫ͞Ϫ MEFs are highly resistant to cell death triggered by ara C (Fig. 4D) . Together with the result that p53 remains high in suspended A375 cells (Fig. 4B) , these results support the hypothesis that the decrease in p53 may account for the diminished sensitivity of suspended cells.
Effects of Adhesion Require Mdm2. These data suggest that decreased Arf in suspended cells may increase Mdm2-dependent degradation of p53. To test this idea, a GFP-p53 construct in which expression is driven by a constitutive promoter was transfected into p53-null MEF cells. The function and posttranslational regulation of this construct is similar to wild-type p53 (5). The exogenous GFP-p53 protein also declined after cell detachment, whereas levels of transfected control GFP did not (Fig. 5A ). This result excludes transcriptional mechanisms for the adhesion-dependent changes in p53 levels. As a further test, we examined MEFs nullizygous for Mdm2. These cells by necessity are also p53-null, hence were transiently transfected with GFP-p53. Lower levels of GFP-p53 DNA were used for these cells to obtain protein levels that did not induce apoptosis without DNA damage. We observed that after 18 h, the decline in p53 in suspended Mdm2-null cells was much less than in Mdm2-positive MEFs (Fig. 5A Bottom) . Taken together, these findings argue that the decrease in p53 in nonadherent cells is due at least in part to the Arf͞Mdm2 degradation pathway.
Restoration of p53.
To test the functional relationship between p53, Arf, and apoptosis, MEF cells were transfected with p53 or Arf at moderate levels that cause only slight apoptosis in the absence of DNA damage. As a marker of transfection, cells were cotransfected with a plasma membrane-targeted GFP construct, GFP-GAP (33). Cells were either untreated or treated with ara C. We observed that elevating p53 or Arf increased sensitivity to ara C in suspended cells nearly to the level found in adherent cells (Fig. 5 B and C) . Although there was some elevation of apoptosis in the suspended GFP-GAP control cells in the Arf reconstitution experiments, statistical analysis showed that the increase in ara C killing in suspended Arftransfected cells relative to suspended GFP-GAP cells is highly significant (P ϭ 0.007).
To confirm that p19Arf expression increased p53 levels, transiently transfected cells were assayed by Western blotting. In cells transfected with the GFP-GAP control alone, p53 in suspended cells declined to 24% of adherent cells (Fig. 5D ). These levels of p53 are slightly higher than untransfected cells, probably indicative of stress caused by transfection. Expression of GFP-Arf caused an increase in p53 in adherent cells (64% above their GFP-GAP counterparts) and substantially inhibited the decline in suspended cells (59% of adherent p19Arf-transfected cells). Given the transfection efficiencies of Ϸ50%, these results indicate that p19Arf expression strongly inhibits the decline in p53 after detachment. Thus, raising levels of p53 or Arf in suspended cells restored the response to DNA damage. We also noted some apoptosis without ara C in adherent but not suspended GFP-p53-expressing cells; this result is consistent with the higher level of GFP-p53 in the adherent cells (Fig. 5A) .
Chromosomal Instability. p53 is critical for maintaining integrity of the genome (34, 35) , and hence decreased p53 in suspended cells could cause genetic instability. Treatment with radiation or chemotherapy then could lead to accumulation of mutations at an elevated rate. As an initial test of this hypothesis, irradiated MEFs were subjected to karyotype analysis. As described before, cells were irradiated while in suspension but then either replated immediately to restore p53 function or maintained in suspension for 2 days before replating. The irradiation caused most of the cells to die; the few surviving cells then were expanded and analyzed. As expected, both irradiated samples contained cells with aberrant chromosomes (Fig. 6) . However, cells kept in suspension contained a significantly larger number of gross chromosomal rearrangements. These data provide evidence that loss of integrin-mediated attachment during times of genotoxic stress may lead to the growth of cells harboring chromosomal rearrangements.
Discussion
These results demonstrate that for several cell types in which survival per se does not require adhesion, integrin-mediated cell adhesion positively regulates the DNA-damage response such that cells maintained in suspension show less apoptosis in response to either radiation or a radiomimetic chemical. The effect is caused by changes first in levels of p19Arf and subsequently in levels of p53 tumor suppressor. Consistent with the reduction in p53, suspended cells also show elevated mutation rates after irradiation. The results presented here suggest that a rapid decrease in Arf levels after cell detachment leads to decreased p53 levels, consistent with the known ability of Arf to suppress MDM2 and prevent p53 degradation (4, 36, 37) . Loss of p53 then mediates the decreased sensitivity to DNA damage. Under some conditions, Arf has been shown to act independently of p53 to cause cell cycle arrest in G 1 (38, 39) . Thus, loss of Arf also may have effects independent of p53 that may alter the DNA-damage response. In addition, c-Abl is both regulated by integrins and involved in the DNA-damage pathway (40, 41) and thus also could contribute to the adhesion-sensitive DNA-damage response.
There have been many studies investigating how loss of integrinmediated adhesion promotes apoptosis in epithelial and endothelial cell types, whereas other cell types including fibroblasts are much less sensitive to detachment. Only under conditions of severe growth-factor deprivation do fibroblastic cells show effects of specific integrins on survival (42) . The mechanisms that account for cell-type specificity are unknown, and it is unclear to what extent integrin protection from cell death in epithelial͞endothelial cells occurs by the same mechanisms as those in less sensitive cell types.
We noted that the carcinoma and epithelial cell lines we tested became apoptotic when detached in the absence of DNA damage. In these cells, there is some evidence for pathways linking integrin ␣6␤4 to activation of p53. Bachelder et al. (21) showed that overexpression of ␣6␤4 integrin in suspended carcinoma cells, where the integrin would be unoccupied by any ECM ligand, activates p53 and induces apoptosis. They also reported that antibody crosslinking of unoccupied integrins accelerated apoptosis; however, this effect is unlikely to reflect interactions of ␣6␤4 with basement membranes, because adhesion to basement membranes promotes epithelial cell survival. p53 also was linked to survival of adherent rabbit synovial fibroblasts or mouse endothelial cells induced by growth-factor deprivation. In that study, focal adhesion kinase-mediated decreased p53 levels and prevented apoptosis (43) . Because integrin ␣6␤4 does not activate focal adhesion kinase, it seems unlikely that these two effects are related, despite the involvement of p53 in both. Furthermore, both of these effects of integrins on p53-dependent apoptosis are quite opposite to those described in our study. Given the opposite direction of the effects, the different conditions and cell types examined, and the large number of pathways known to activate p53, there are no compelling reasons to believe that these distinct effects are related.
The pathways by which integrin-mediated adhesion regulates Arf levels are unknown currently. Integrins have been shown to stimulate the classical mitogen-activated protein kinase pathway (44) (45) (46) , which when strongly activated by oncogenic Ras can increase both Arf and Mdm2 levels (47) . However, the mitogen-activated protein kinase kinase inhibitor PD98059 had no effects on Arf in MEF cells (data not shown and ref. 48 ), arguing against a role for Erk in this system. Arf expression is induced also by deathassociated protein kinase and the transcription factors DMP1 and E2F1 after activation of the oncogenes c-myc and c-ras; it is opposed by Twist and Bmi1 (49) . Because integrins control the activity or levels of several of these components (50, 51) , there are a number of candidate pathways that might mediate the effects of adhesion on Arf.
Our findings provide a mechanistic link between cell adhesion and DNA damage-induced apoptosis and may have implications for models of tumor cell progression. First, tumor cells in vivo that are poorly adherent may escape killing induced by DNA-damage therapy. Second, such cells may show enhanced accumulation of mutations after DNA damage, which would thereby accelerate progression. Finally, our data might offer a new strategy for therapy, in which ligating integrins or stimulating the relevant integrin pathway may be effective as an adjunct to conventional radiation and chemotherapies to enhance killing of poorly adherent tumor cells.
